No species has a greater claim to pre-eminence as a subject for the study of blood pressure than the dog. The Rev Stephen Hales published far more observations in dogs than those immortalized in his portrayal beside a recumbent horse; moreover his measurements fall in a remarkably credible range. The Goldblatt model of hypertension originated in dogs, not rats; so too did Guyton's concept of the role of the kidney in long-term regulation of blood pressure.
Public opposition and ®nancial pressures have almost ended this tradition of using dogs as models for human disease. But a new era of synergy between canine and human medicine could emerge from the growing range of minimally invasive techniques applicable to quantitative study of clinical disorders. By allowing the study of complex multifactorial diseases in a way that combines authenticity with acceptability, work in dogs may have even more to contribute to the future of comparative medicine in its original senseÐthe open-minded study of comparable diseases in different species, with lessons drawn from the similarities and especially from the contrasts.
So, what are the special attributes of the dog for studies in comparative medicine? Here are six:
. A huge range of body size within a single species . Despite their unusual phenotype diversity, exempli®ed by differences between breeds, dogs have remarkable genotype homogeneity compared with human ethnic groups 1 . Thus, for example, the existence of substantial differences in longevity between otherwise similar breeds offers unique material for studies of the clinical biology of senescence 2 , as does the fact that geriatric diseases can be expected at 6±16 years of age, rather than after 60 . Breeding and nutrition are controllable factors . Size allows that clinical techniques applicable to children are potentially applicable to dogs . Where intra-uterine or perinatal factors may be key determinants of disease (see, for instance, the Barker hypothesis of cardiovascular destiny 3 ), dogs offer the advantages of short gestation, multiple births and rapid maturation . No species is as accessible and amenable as the welltrained pet dog.
Dogs resemble human beings in that their blood pressure varies greatly in the course of the day 4 . Hales knew this 4 , but modern textbooks of physiology shy away from the variability because they prefer to emphasize arterial pressure as an example of`set point' negative feedback regulation. Ambulatory measurements in dogs con®rm the complex and inescapable variability of blood pressure, hence the importance of a series of readings 5 . In a cuff-based technique the ®rst reading simply seats the cuff, and at least six readings are desirable, with the ®rst discarded 5, 6 . Using the canine technique in man, I noted that readings differed not only with time of day but also according to whether it was a working day 7 . This has implications for a condition such as diabetic glomerulo-pathyÐthe commonest cause of end-stage renal failureÐ in which the glomeruli are vulerable to even a small increase in blood pressure 8 . It is disturbing that pressures are still commonly checked with single, casual, ratings. Dogs show evidence of white coat effects, sex differences, tracking' (repeatable rankings within a cohort over time), age-related rises in blood pressure, and increased pressures with obesity and with Cushing's syndrome and diabetes 9±11 Ði.e. patterns which would be expected if they were human. Moreover, as with many human beings, their dietary sodium consumption is tenfold above requirement, so both species show the age-related rise in pressure associated with excess salt 12 . Dogs with chronic renal insuf®ciency are less likely than their human equivalents to become hypertensive 13 . More interesting is the fact that certain breeds (the`sight hounds'Ðgreyhounds, deerhounds) have`normal' pressures well into the human hypertensive range 14 yet escape end organ damage. These are not passive, un®t animals but breeds that are strikingly athletic. Do they perhaps offer insight into evolutionary advantages which co-selected with high pressure when human beings were athletic and short-lived?
Most patients with chronic renal failure (CRF) become hypertensive, and the hypertension, in turn, is likely to accelerate progression of the renal failure. In the 1980s, three concepts came to dominate human nephrology 15 . First, the factors sustaining progression of CRF were seen as substantially independent of those initiating it. This was EDITORIAL 451 JOURNAL OF THE ROYAL SOCIETY OF MEDICINE encouraging because such`self-sustaining progression' was a more accessible target for research, and potentially for clinical intervention, than the original cause. Second, the compensatory increase in the glomerular ®ltration rate of surviving intact nephrons, while moderating the overall decline in ®ltration, was thought to hasten their eventual demise. Third, protein (or rather the resulting aminoacids), as a cause of`hyper®ltration', was thought to exacerbate progression, thus reduced intake might slow progression. Unfortunately, except in diabetes, this seems to be untrue in man; and work in dogs suggested that linear progression' was, if anything, a late event in renal disease, unin¯uenced by dietary protein.
Renal disease is not uncommon in dogs and offers a spontaneous model of a condition which is hard to recreate in laboratory animals since it probably involves cumulative interaction between immune-mediated, toxic and genetic factors. In fact, other than reduction of GFR, it has little in common with the effects of subacute subtotal nephrectomy in laboratory rodents. Thus while rodent models may offer the means of exploring single candidate mechanisms, dogs potentially offer better spontaneous authentic models of multifactorial diseases; for example, dogs could provide a better test of therapeutic or prophylactic intervention in CRF, whether dietary or pharmaceutical.
In hypertension the focus of canine research should be the high-pressure breeds. Do they show evidence of renal, cardiovascular or retinal damage? Do deerhounds, with their high cholesterol levels, show evidence of atherosclerosis (indicated, for example, by carotid intimal thickness on ultrasound scanning)? Do they show increased tortuosity of retinal vessels? Are they truly hypertensive, or do they have an adaptive increase in arterial pressure? Are the genetic factors associated with increased pressure in these breeds similar to those, such as angiotensinogen gene polymorphism 16 , likely to predispose to human hypertension?
I have focused on hypertension and renal disease. But the potential for comparative studies is far broader. Breed differences in predisposition to speci®c tumours offer potential insights into oncogenesis. Diseases of shared environments could pro®tably be studied togetherÐe.g. the role of dust mites in human asthma and canine skin allergies. Where exposure to environmental pollutants or household contaminants is shared, coordinated comparative studies could again be rewarding. Human infants with acute diarrhoea might bene®t from new approaches to oral dehydration developed in animals 17 . Greater understanding of comparative medicine can also help to avoid pseudocomparative' medicine based on misconceptions such as the idea that pregnancy toxaemia in sheep (ketoacidosis caused by twin gestation) or eclampsia in bitches (hypocalcaemia) might throw light on human pregnancy toxaemia.
Over a hundred years ago Mills remarked that comparative medicine is the medicine of the future and the sooner that is realised the better for man as well as beast' 18 . Until now the trend has been to focus almost exclusively on zoonoses among the diseases which are shared with animals. But we also share much of our genetic heritage, and, therefore, the mechanisms that dictate our susceptibility to disease 19 . A proper emphasis on comparative medicine will allow us to share not only our diseases but also the bene®ts of understanding them.
